6-Monoacetylmorphine (6-MAM) Rapid Test Device

6-Monoacetylmorphine, commonly called 6-MAM or 6-Acetylmorphine, is a metabolite linked with heroin metabolism. In drug screening, it is valued because it is considered more specific to heroin exposure than general opiate markers such as morphine.

The 6-MAM Rapid Test Device is intended for professional urine-based screening support. It helps trained users identify urine samples that may require further review or confirmatory testing according to laboratory policy.

Applications

• Drug of abuse screening programs
• Toxicology laboratories
• Rehabilitation and de-addiction centers
• Occupational health screening
• Emergency and clinical screening settings
• Forensic and compliance screening support
• Institutional drug monitoring programs

The 6-MAM Rapid Test Device is designed for qualitative detection of 6-MAM in urine at the stated 50 ng/mL cut-off. Rapid urine drug screening devices commonly use immunoassay-based principles to provide a preliminary visual result.

Benefits

• Fast preliminary screening support
• Simple urine sample workflow
• No complex instrument required for basic screening
• Useful for heroin metabolite screening
• Suitable for professional testing environments
• Supports screening before confirmatory laboratory methods
• Practical format for international diagnostic supply

The 6-MAM Rapid Test Device uses urine as the specimen. Proper sample collection, handling, and interpretation are important for reliable screening performance.

Guidance

• Use urine specimens only
• Collect urine in a clean and dry container
• Follow the exact sample volume and testing steps in the product insert
• Avoid contaminated or improperly stored urine samples
• Use the test device immediately after opening the sealed pouch
• Read the result only within the approved time window
• Do not reuse the test device

• 6-MAM testing is useful because 6-MAM is associated specifically with heroin metabolism and may help support heroin-focused screening workflows.
• Because 6-MAM can have a short detection window, a positive result may be meaningful, while a negative result does not always rule out previous exposure.
• Results should be interpreted by trained professionals together with sample history, testing policy, chain-of-custody requirements where applicable, and confirmatory methods when needed.

Positive

A positive result suggests that 6-MAM may be present in the urine specimen at or above the stated cut-off. The result should be treated as preliminary unless confirmed by a validated laboratory method.

Negative

A negative result suggests that 6-MAM was not detected or was below the test detection level at the time of testing. It does not always rule out previous exposure.

Invalid

If the control indicator does not appear, the result is invalid. The test should be repeated with a new 6-MAM Rapid Test Device and a suitable urine specimen.

The 6-MAM Rapid Test Device is a professional screening-support test. It should not replace confirmatory testing, medical judgment, laboratory policy, or legal procedures where those are required.

Guidance

• Use only for professional in vitro diagnostic screening support
• Follow the official product insert carefully
• Do not use expired or damaged devices
• Do not reuse the test device
• Avoid contaminated samples
• Interpret results within the recommended time only
• Confirm positive results through appropriate laboratory methods where required

Instructions

• Store in a clean and dry place
• Keep away from direct sunlight
• Protect from excessive heat and moisture
• Keep sealed until use
• Use before the expiry date
• Do not use if the pouch is damaged
• Follow the printed temperature range on the pack

LARKSOIS Pharma provides diagnostic products for international healthcare, laboratory, and distribution markets with a focus on professional product presentation and dependable screening support.

Advantages

• Urine-based rapid screening format
• 50 ng/mL cut-off level
• Targets 6-Monoacetylmorphine specifically
• Supports heroin metabolite screening
• Suitable for drug of abuse testing programs
• Useful for professional laboratory workflows
• International product positioning under LARKSOIS Pharma